Galectin Therapeutics Inc.GALTNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank60
3Y CAGR-11.7%
5Y CAGR-9.4%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
-11.7%/yr
Annual compound
5Y CAGR
-9.4%/yr
Consistent
Percentile
P60
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$22000.00-40.5%
2024$37000.00+12.1%
2023$33000.00+3.1%
2022$32000.00-22.0%
2021$41000.00+13.9%
2020$36000.00+2.9%
2019$35000.00-
2018$0.00-100.0%
2017$1000.00-85.7%
2016$7000.00-